Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Code

Type your Poster Code, then hit apply

Showing 1,267 results.

Thumbnail for Digital PCR versus qPCR for BCR::ABL1 Monitoring and Treatment-Free Remission Prediction in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis

CML - 1127

Digital PCR versus qPCR for BCR::ABL1 Monitoring and Treatment-Free Remission Prediction in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis

Amal Paul

Poster Presenter: Amal Paul

Thumbnail for Sequential Enumeration of CD26+ Leukemic Stem Cells and Its Correlation With BCR::ABL1 Transcript Levels in Chronic Myeloid Leukemia at Diagnosis and During Tyrosine Kinase Inhibitor Therapy

CML - 1129

Sequential Enumeration of CD26+ Leukemic Stem Cells and Its Correlation With BCR::ABL1 Transcript Levels in Chronic Myeloid Leukemia at Diagnosis and During Tyrosine Kinase Inhibitor Therapy

Praveen Sharma

Poster Presenter: Praveen Sharma

Previous 1...57 58 59 60 61 62 63...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Efficacy and Safety of Asciminib Dose Escalation in Patients with Chronic Myeloid Leukemia (CML) without Optimal Response to the Standard Dose

CML - 1134

Efficacy and Safety of Asciminib Dose Escalation in Patients with Chronic Myeloid Leukemia (CML) without Optimal Response to the Standard Dose

Elza Lomaia

Poster Presenter: Elza Lomaia

Thumbnail for Phenotype-Specific Safety Reporting Signals of Asciminib Versus Second- and Third-Generation Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A FAERS Disproportionality Analysis

CML - 115

Phenotype-Specific Safety Reporting Signals of Asciminib Versus Second- and Third-Generation Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A FAERS Disproportionality Analysis

Edward Mwarangu

Poster Presenter: Edward Mwarangu

Thumbnail for Cardiac Safety of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Real-World Propensity-Matched Comparison of Dasatinib, Nilotinib, and Imatinib

CML - 1166

Cardiac Safety of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Real-World Propensity-Matched Comparison of Dasatinib, Nilotinib, and Imatinib

Rukash Khan Niazi

Poster Presenter: Rukash Khan Niazi

Thumbnail for A Novel BCR::ABL1 I502T Mutation Associated With Acquired Asciminib Resistance in Chronic-Phase Chronic Myeloid Leukemia

CML - 1215

A Novel BCR::ABL1 I502T Mutation Associated With Acquired Asciminib Resistance in Chronic-Phase Chronic Myeloid Leukemia

Rahul Kumar Thakur

Poster Presenter: Rahul Kumar Thakur

Thumbnail for Early CD26? Leukemic Stem Cell Kinetics Can Predict Suboptimal Molecular Response and Switching TKIs during Chronic-Phase CML Therapy

CML - 1221

Early CD26? Leukemic Stem Cell Kinetics Can Predict Suboptimal Molecular Response and Switching TKIs during Chronic-Phase CML Therapy

Rudra Narayan Swain

Poster Presenter: Rudra Narayan Swain

Thumbnail for Divergent Trends in Chronic Myeloid Leukemia Mortality Associated with Cardiovascular Comorbidities in the United States (2018-2024): A CDC WONDER and GBD Analysis Highlighting Persistent Survivorship Risk

CML - 124

Divergent Trends in Chronic Myeloid Leukemia Mortality Associated with Cardiovascular Comorbidities in the United States (2018-2024): A CDC WONDER and GBD Analysis Highlighting Persistent Survivorship Risk

Tapan Giri

Poster Presenter: Tapan Giri

Thumbnail for Atherothrombotic adverse effects of tyrosine kinase inhibitors in patients with chronic myeloid leukemia

CML - 1247

Atherothrombotic adverse effects of tyrosine kinase inhibitors in patients with chronic myeloid leukemia

Nadezhda Shnalieva

Poster Presenter: Nadezhda Shnalieva

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.